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Calcitonin Gene-Related Peptide and Calcitonin in MEN-2 and
Sporadic Pheochromocytomas: An Immunohistochemical Study
Lis Johannsen,* Henrik Daa Schroder, and Soren Schifter

Ten pheochromocytomas (five from patients with mulliple endocrine neoplasia type 2 and five
sporadic) were stained immunohistochemically with antibodies to calcitonin (CT) and calcitonin
gene-related peptide (CGRP) by means ofthe peroxidase-antiperoxidase method. CGRP positive cells
were found in variable numbers in all of the investigated tumors. No demonstrable difference was
noted between the hereditary tumors and the sporadic tumors. Staining with CT antibody also showed
cells whh a positive reaction in eight often tumors. The distribution of the Two peptides was similar,
and in some cells their coexistence was visualized. Pheochromocytomas thus represent an alternative
site to medullary thyroid carcinoma for CT and CGRP production. The possible influence of this on
serum peptide levels needs investigation. (Henry Ford Hosp MedJ 1987;35:115-7)

heochromocytoma and medullary thyroid carcinoma
(MTC) are found as sporadic tumors and as part of the multiple endocrine neoplasia type 2 (MEN-2) syndrome. In MTC,
immunochemical and immunohistochemical demonstration of
calcitonin (CT) and possibly CT gene-related peptide (CGRP)
play an important role in diagnosis, follow-up, and even in the
distinction between sporadic and hereditary tumors (1-3). Since
a genetic link exists between MTC and the pheochromocytoma
in MEN-2, we investigated whether or not CT and CGRP were
produced in the pheochromocytomas, and i f immunohistochemical studies of these peptides would reveal differences
between sporadic and hereditary pheochromocytomas.

P

Materials and Methods
Ten surgically removed pheochromocytomas were studied:
five tumors from patients without any known hereditary disposition, andfivefrom four patients with the MEN-2 syndrome (one
had a new pheochromocytoma in the opposite gland three years
after removal of the initial tumor).
Four to six p.m formalin-fixed, paraffin-embedded tissue material sections (initially rehydrated in graded alcohol and rinsed
in phosphate-buffered saline at pH 7.1) were stained using
the peroxidase-antiperoxidase (PAP) technique (4) with diaminobenzidine (0.05%) for visualization. False-positive staining due to endogenous peroxidase was prevented by treatment
with 35% HjO, in methanol for 40 minutes. The three layers in
the PAP staining consisted of rabbit antibody against CGRP
(polyclonal) (2) or CT (polyclonal from DAKO, Denmark,
monoclonal from Nordic), followed by swine-anti-rabbit-Ig,
and finally the peroxidase-rabbit-antiperoxidase complex. Fetal
calf serum (1%) was added to prevent nonspecific absorption before addition of each layer of antibody in the three-layer technique. Incubation with the primary antiserum (dilution 1/800)
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was for 18 hours at 4°C, and with swine-anti-rabbit-Ig and the
PAP complex for 30 minutes each. Sections from a MTC were
used as positive controls.
Thin (2 to 3 p,m) serial sections were cut and stained for
CGRP and CT to demonstrate more clearly the relationship
between the distribution of the two peptides.

Results
Cells with positive reaction with CGRP antibody (Ab) were
found in all the tumors investigated. Numbers varied from only a
few scattered cells to a more pronounced reaction in a large
number of cells. The intensity of the reaction in the cells likewise was variable, ranging from faint to very dark staining cells.
Staining with Ab to CT showed cells with positive granules in
eight of ten tumors. Two sporadic tumors, however, showed no
positive reaction, and one of the hereditary tumors contained
only a few positive cells whereas another tumor showed only
faint but widespread positive reaction. In most cases the distribution of CT positive cells was similar to that of the CGRP
positive cells, and CT staining showed similar variation from
only slight to pronounced reaction, and from a few to numerous
cells. Study of adjacent 2 to 3 |xm sections showed that some
cells contained both CT and CGRP, but that other cells stained
for only one peptide.
Comparison of sections of tumor from patients with MEN-2
(Figs 1 and 2) with those from sporadic cases (Fig 3) showed no
convincing difference in either content or distribution of the
peptides. The density of positive cells was found to be somewhat
less in pheochromocytomas than in the MTC used as a control.
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F/'g 7—Staining for CGRP in pheochromocytoma from patient with the MEN-2 syndrome.
Many positive cells are present. (PAP method) (X 125).
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Fig 2—Staining for CGRP in pheochromocytoma from MEN-2 patient. Only afew scattered
positive cells are noted. Two positive cells are shown at higher magnification (see arrows)
(PAP method) (X 100) (Insets X1200).
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Fig 3~Sporadic pheochromocytoma. Serial sections, 2-3 [im. A) Staining for CT. B) Staining
for CGRP. Cells positive for both peptides (arrow at left), as well as cells positivefor only CGRP
(arrows at center and right) are seen. Some ofthe CGRP positive cells show slender cytoplasmic
extensions (bottom inset) (PAP method) (X100) (InsetsX 960 and 1,200).

Discussion
CT has been demonstrated previously in pheochromocytomas
(5). The present study confirms this and extends the observations
to include both sporadic and hereditary (MEN-2) tumors. The
distribution of CGRP-containing cells was similar to that of CTcontaining cells, and coexistence of the peptides in some cells
was observed as might be expected considering the close genetic
relationship of the two peptides (6,7).
The positive reaction for CGRP and CT in these tumors suggests a possible diagnostic value of serum determinations in patients with suspected pheochromocytomas. In MEN-2, the
raised levels of plasma CGRP and plasma CT might not be
exclusively related to production by MTC, since pheochromocytomas constitute an altemative site of production ofthese peptides. Further investigations are indicated to clarify the influence
of pheochromocytomas on serum CGRP and CT.
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